Vikrant Vijay Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Staff Fellow (Pharmacologist)

National Center for Toxicological Research

staff

16 h-index 45 pubs 1,147 cited

Research Areas

Pharmacological Effects and Toxicity Studies Cancer Treatment and Pharmacology Cardiovascular Function and Risk Factors MicroRNA in disease regulation Metabolomics and Mass Spectrometry Studies Meta-analysis and systematic reviews SARS-CoV-2 and COVID-19 Research

Links

ORCID Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Vikrant Vijay's research focuses on the pharmacological effects and toxicity of various therapeutic agents, particularly in the context of cancer treatment and cardiovascular health. His work has investigated the cardiotoxic effects of doxorubicin, exploring mechanisms such as delayed-onset subclinical cardiotoxicity and the role of the apelin-APJ pathway in sex-related differential toxicity. Vijay has also examined the potential of microRNA-34a-5p as a circulating biomarker for doxorubicin-induced chronic cardiotoxicity and explored the use of induced pluripotent stem cell-derived cardiomyocytes for predicting oncology drug-induced cardiotoxicity. His research extends to identifying biomarkers for disease severity, as seen in his work on COVID-19 patient plasma, and includes systematic reviews on pediatric pharmacokinetics. Vijay has co-authored publications with researchers from the National Center for Toxicological Research and the University of Arkansas for Medical Sciences, contributing to a total of 45 publications with over 1,100 citations.

Metrics

  • h-index: 16
  • Publications: 45
  • Citations: 1,147

Selected Publications

  • Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study (2026) DOI
  • Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study (2025) DOI
  • Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers (2024) DOI
  • Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin (2024) DOI
  • Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice (2022) DOI
  • MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity (2022) DOI
  • Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice (2021) DOI
  • Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology (2021) DOI

Collaborators

Researchers in the database who share publications

Bounleut Phanavanh National Center for Toxicological Research 5 shared publications James C. Fuscoe National Center for Toxicological Research 4 shared publications Kimo C. Stine University of Arkansas for Medical Sciences 4 shared publications Carrie L. Moland National Center for Toxicological Research 3 shared publications David P. Douglass University of Arkansas for Medical Sciences 2 shared publications David P. Douglass University of Arkansas for Medical Sciences 2 shared publications Nysia I. George National Center for Toxicological Research 2 shared publications Richard D. Beger National Center for Toxicological Research 2 shared publications

Similar Researchers

Based on overlapping research topics

Maham Bakhtyar University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Cancer Treatment and Pharmacology Cardiovascular Function and Risk Factors
Good match 5 shared topics
Carrie L. Moland National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies Cancer Treatment and Pharmacology Cardiovascular Function and Risk Factors
Good match 4 shared topics
James C. Fuscoe National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies Cancer Treatment and Pharmacology Cardiovascular Function and Risk Factors
Good match 4 shared topics
Valentina K. Todorova University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Cancer Treatment and Pharmacology Cardiovascular Function and Risk Factors
Good match 5 shared topics
Bounleut Phanavanh National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies Cancer Treatment and Pharmacology Cardiovascular Function and Risk Factors
Good match 4 shared topics
Amber Morse University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Cancer Treatment and Pharmacology Cardiovascular Function and Risk Factors
Good match 4 shared topics